188 related articles for article (PubMed ID: 36219797)
41. Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis.
Ilia TS; Dragoumi P; Papanikolopoulou S; Goulis DG; Pavlou E; Zafeiriou D
Seizure; 2022 Jan; 94():117-125. PubMed ID: 34896814
[TBL] [Abstract][Full Text] [Related]
42. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
Yu L; Feng J; Yu Z; Dai H
Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
[TBL] [Abstract][Full Text] [Related]
43. Antiseizure medication in patients with Glioblastoma- a collaborative cohort study.
Knudsen-Baas KM; Storstein AM; Zarabla A; Maialetti A; Giannarelli D; Beghi E; Maschio M
Seizure; 2021 Apr; 87():107-113. PubMed ID: 33761391
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
Kanemura H; Sano F; Ohyama T; Aihara M
Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
[TBL] [Abstract][Full Text] [Related]
45. Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
Zhang Q; Yang F; Hu Z; Zhang Z; Xu Q; Dante M; Wu H; Li Z; Li Q; Li K; Lu G
Eur Radiol; 2017 May; 27(5):2137-2145. PubMed ID: 27553940
[TBL] [Abstract][Full Text] [Related]
46. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy.
Durá-Travé T; Gallinas-Victoriano F; Malumbres-Chacón M; Moreno-Gónzalez P; Aguilera-Albesa S; Yoldi-Petri ME
Epilepsy Res; 2018 Jan; 139():80-84. PubMed ID: 29197669
[TBL] [Abstract][Full Text] [Related]
47. Testing association of rare genetic variants with resistance to three common antiseizure medications.
Wolking S; Moreau C; Nies AT; Schaeffeler E; McCormack M; Auce P; Avbersek A; Becker F; Krenn M; Møller RS; Nikanorova M; Weber YG; Weckhuysen S; Cavalleri GL; Delanty N; Depondt C; Johnson MR; Koeleman BPC; Kunz WS; Marson AG; Sander JW; Sills GJ; Striano P; Zara F; Zimprich F; Schwab M; Krause R; Sisodiya SM; Cossette P; Girard SL; Lerche H;
Epilepsia; 2020 Apr; 61(4):657-666. PubMed ID: 32141622
[TBL] [Abstract][Full Text] [Related]
48. Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication?
Zaccara G; Lattanzi S; Brigo F
Epilepsy Behav; 2021 Aug; 121(Pt A):108031. PubMed ID: 33992932
[TBL] [Abstract][Full Text] [Related]
49. Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study.
Tinchon A; Oberndorfer S; Marosi C; Gleiss A; Geroldinger A; Sax C; Sherif C; Moser W; Grisold W
J Neurol; 2015 Jan; 262(1):179-86. PubMed ID: 25359262
[TBL] [Abstract][Full Text] [Related]
50. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Chowdhury A; Brodie MJ
Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
[TBL] [Abstract][Full Text] [Related]
51. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
52. Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy.
Schelhaas M; Wegner I; Edens M; Wammes-Van Der Heijden E; Touw D; Ter Horst P
Neurology; 2023 Jan; 100(2):e172-e181. PubMed ID: 36257713
[TBL] [Abstract][Full Text] [Related]
53. Lacosamide Lowers Valproate and Levetiracetam Levels.
Tountopoulou M; Weschke B; Kaindl AM
Neuropediatrics; 2017 Jun; 48(3):188-189. PubMed ID: 28324910
[TBL] [Abstract][Full Text] [Related]
54. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R
Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
[TBL] [Abstract][Full Text] [Related]
55. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
García C; Rubio G
Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
[TBL] [Abstract][Full Text] [Related]
57. Trends in Prescribing of Antiseizure Medications in South Korea: Real-World Evidence for Treated Patients With Epilepsy.
Kang KW; Lee H; Shin JY; Moon HJ; Lee SY
J Clin Neurol; 2022 Mar; 18(2):179-193. PubMed ID: 35274836
[TBL] [Abstract][Full Text] [Related]
58. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Shukla G; Gupta A; Agarwal P; Poornima S
Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
[TBL] [Abstract][Full Text] [Related]
59. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
Consoli D; Bosco D; Postorino P; Galati F; Plastino M; Perticoni GF; Ottonello GA; Passarella B; Ricci S; Neri G; Toni D;
Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439
[TBL] [Abstract][Full Text] [Related]
60. Effect of levetiracetam and oxcarbazepine on 4-year fragility fracture risk among prepubertal and pubertal children with epilepsy.
Whitney DG; Caird MS; Hurvitz EA; Rajapakse CS; Fedak Romanowski EM
Epilepsia; 2021 Sep; 62(9):2180-2189. PubMed ID: 34250606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]